37 papers
Health economics explores the vital intersection where medical care meets financial reality, examining how resources are allocated, costs are managed, and value is determined in healthcare systems. This field goes beyond simple budgeting to investigate how policy decisions and pricing strategies impact patient access and public health outcomes. By analyzing the economic drivers behind medical treatments, researchers aim to create more sustainable and equitable systems for everyone.
On Gist.Science, we process every new preprint in this category directly from medRxiv, ensuring you have immediate access to the freshest research as it emerges. Our team transforms these complex studies into both plain-language overviews for general readers and detailed technical summaries for specialists, bridging the gap between raw data and actionable insight. Below are the latest papers in health economics, curated to help you navigate the evolving landscape of medical finance and policy.
A modeling study in the Netherlands demonstrates that the next-generation mRNA-1283 vaccine is projected to significantly reduce COVID-19 infections, hospitalizations, and deaths while offering substantial health and economic benefits over existing vaccines, supporting its continued use in national vaccination programs.
An updated cost-effectiveness analysis incorporating new evidence from over 85 million individuals confirms that high-dose inactivated influenza vaccination is highly cost-effective for adults aged 60 and older in the Netherlands, supporting its inclusion in the national immunization program.
Based on 2022 data from 624 rural Nigerian households, this study reveals that access to inpatient healthcare is significantly stratified by income and region, with poorer households disproportionately utilizing public primary and secondary facilities while wealthier groups access tertiary and private care, driven primarily by economic status and geographic location.
This empirical study of 625 rural Nigerian households reveals that multidimensional healthcare access remains critically inadequate, with only 12.5% of households achieving sufficient access, driven by significant supply-side constraints and financial barriers that necessitate expanded health insurance coverage alongside improvements in facility availability and quality.
While scaling up interventions under South Africa's 2023-2028 National Strategic Plan is highly cost-effective and will significantly reduce TB incidence and mortality, it falls short of meeting the 2030 End TB targets, necessitating further efficiency improvements and the development of new tools like low-cost diagnostics and vaccines.
This retrospective study of 214 hospitalized children across 16 Kenyan public hospitals reveals that treating pediatric measles incurs a median societal cost of USD 176.18 per admission, primarily driven by staff and bed expenses, and places more than half of affected households at risk of catastrophic health expenditure, underscoring the urgent need for expanded insurance coverage and improved resource allocation.
This modelling study estimates that mandatory calorie labelling for large out-of-home businesses in England is likely to be cost-effective and generate modest health benefits, particularly for deprived populations, primarily driven by expected changes to restaurant menus rather than consumer behaviour alone.